SCHEMBL7965455

SCHEMBL7965455

N#C/C(=C/c1ccc(O)c(O)c1)S(=O)(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.70
ALDH1A1 P00352 5/20 0.70
KMT2A Q03164 5/20 0.70
L3MBTL1 Q9Y468 4/20 0.70
MEN1 O00255 4/20 0.70
HPGD P15428 4/20 0.70
HSD17B10 Q99714 4/20 0.70
PKM P14618 3/20 0.70
ALOX15 P16050 3/20 0.70
ALOX12 P18054 3/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
TDP1 Q9NUW8 3/20 0.70
POLB P06746 3/20 0.70
ALPG P10696 2/20 0.70
GAA P10253 1/20 0.70
EGFR P00533 9/20 0.56
ERBB2 P04626 6/20 0.54
TP53 P04637 3/20 0.43
CYP1A2 P05177 3/20 0.43
MAPT P10636 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965453 1.00 KDM4E (0.70) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7965458 1.00 KDM4E (0.70) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7964402 0.88 PKM (0.54) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7964397 0.88 PKM (0.54) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7964398 0.88 PKM (0.54) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7966641 0.87 HPGD (0.70) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7966639 0.87 HPGD (0.70) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7966634 0.87 HPGD (0.70) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7964960 0.85 MEN1 (0.50) KDM4EALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL7964954 0.85 MEN1 (0.50) KDM4EALDH1A1KMT2AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed